medigraphic.com
ISSN 1025-0298 (Electronic)
ISSN 1025-028X (Print)

2019, Number 3

<< Back Next >>

VacciMonitor 2019; 28 (3)

Importance of household mite allergens in the diagnosis of allergic rhinitis with sleep apneahypopnea syndrome

Rodríguez-Santos O, García-Asensi A, Ponce ÁC, Galeana RR, Jardines AG, del Valle MN

Language: Spanish
References: 19
Page: 97-102
PDF size: 271.55 Kb.


ABSTRACT

The mites Dermatophagoides pteronyssinus (Dp), Dermatophagoides siboney (Ds) and Blomia tropicalis (Bt) are the primary tool for the diagnosis and immunotherapy of Allergic Rhinitis (AR), which is often associated with the Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS). To diagnose OSAHS, 465 individuals were selected from the allergy registry of the “Previsora” Polyclinic, Camagüey, Cuba, with presumptive diagnosis of AR. Those with a skin test (Prick test) negative to Dp, Ds and Bt, and without a previous Cardiorespiratory Polygraphy (CRP) were discarded, leaving 236 patients between 8 and 70 years old: 102 cases (43.2%) those with oral breathing and snoring and 134 controls (56.7%) without oral breathing or snoring. The CRP data analysis was performed using the automatic algorithm of the ApneaLink AirTM device (Resmed Corp., Germany). The average size of the wheal was 5.9 mm in cases (p = 0.02). The Apnea Hypopnea Index (AHI) was greater than 5 events/hour in 129 patients (54.6%); of those, 97 cases (41.1%) and 32 controls (13.5%). Patients with AHI˃20/h predominated in cases with 21 individuals (8.8%) (p꞊0.048). The sensitivity of the PCR was 95.10%, its specificity 76.12%. The positive and negative predictive values were 75.19% and 95.33% respectively. The positive likelihood ratio was 3.98 and the negative one was 0.06. The prevalence of OSAHS was significantly higher in cases compared to controls (p =0.002). The CRP with the ApneaLink device allows the diagnosis of SAHOS in AR.


REFERENCES

  1. Zheng M, Wang X, Zhang L. Association between allergic and nonallergic rhinitis and obstructive sleep apnea. Curr Opin Allergy Clin Immunol 2018;18(1):16-25.

  2. Cao Y, Wu S, Zhang L, Yang Y, Cao S, Li Q. Association of allergic rhinitis with obstructive sleep apnea: A meta-analysis. Medicine (Baltimore) 2018;97(51)e13783. doi: 10.1097/ MD.0000000000013783.

  3. Zheng M, Wang X, Ge S, Gu Y, Ding X, Zhang Y, et al. Allergic and non-allergic rhinitis are common in obstructive sleep apnea but not associated with disease severity. J Clin Sleep Med. 2017;13(8):959-66.

  4. Rodríguez SO, del Valle MN. Inmunoterapia con extractos industriales de ácaros domésticos en niños menores de 5 años de edad con rinitis y asma. VacciMonitor 2018;27(2):61-6.

  5. American Academy of Sleep Medicine. International Classification of Sleep Disorder: Diagnostic and Coding Manual. 2ndEdn. Westchester (NY): American Academy of Sleep Medicine; 2005.

  6. Olivi RH. Apnea del sueño: cuadro clínico y estudio diagnóstico. Rev. Med. Clin. Condes 2013;24(3):359-73.

  7. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of Sleep disorders breathing among middle aged adults. N Engl J Med 1993;328:1230-6.

  8. Durán J, Esnaola S, Ramón R, Iztueta A. Obstructive sleep apneahypopnea and related clinical features in a popilation-based sample of subjects aged 30 to 70 years. Am J Respir Crit Care Med 2001;163:685-9

  9. Seiler A, Camilo M, Korostovtseva L, Haynes AG, Brill AK, Horvath T, et al. Prevalence of sleep-disordered breathing after stroke and TIA: A meta-analysis. Neurology 2019;92(7):e648-54. doi: 10.1212/WNL.0000000000006904.

  10. ResMed. ApneaLinkTM Air Application Software Version 10.2 [CD-ROM]. Martinsried, Munich: ResMed; 2015.

  11. Beaglehole R, Bonita R, Kjellström T. Epidemiologia Básica. Washington D.C: OPS; 1994.

  12. Combs D, Shetty S, Parthasarathy S. Advances in positive airway pressure treatment modalities for hypoventilation syndrome. Sleep Med Clin. 2014;9(3):315-25.

  13. Shintaro C, Parque CS. Establishment of a nasal patent passage in the obstructive apnea. Sleep Med Clin. 2019;14(1):41-50.

  14. Magliulo G, Iannella G, Ciofalo A, Polimeni A, De Vincentis M, Pasquariello B, et al. Nasal pathologies in patients with obstructive sleep apnoea. Acta Otorhinolaryngol 2019 Mar 25. doi: 10.14639/0392-100X-2173.

  15. Gadi G, Wali S, Koshak E, Albar M, Fida A, Abdelaziz M, et al. The prevalence of allergic rhinitis and atopic markers in obstructive sleep apnea. J Epidemiol Glob Health 2017;7(1):37-44.

  16. Lloberes P, Durán-Cantolla J, Martínez-García MÁ, Marín JM, Ferrer A, Corral J, et al. Diagnóstico y tratamiento del síndrome de apneas-hipopneas del sueño. Arch Bronconeumol. 2011;47(3):143- 56.

  17. Parejo-Gallardo K, Saltos-Cristiano CM. Tratamiento médico del síndrome de apnea-hipopnea obstructiva del sueño (SAHOS). Rev. Fac. Med. 2017;65:S101-3. doi: 10.15446/revfacmed. v65n1Sup.59727

  18. Londoño-Palacio N, Machado C. Síndrome de apnea-hipopnea obstructiva del sueño y enfermedades respiratorias. Rev. Fac. Med. 2017;65:S77-80. doi: 10.15446/revfacmed.v65n1Sup.59526

  19. Luna PC. Prevalencia del ronquido y otros síntomas de obstrucción respiratoria alta durante el sueño en una población pediátrica: su relación con el asma y la rinitis alérgica [tesis]. Madrid: Universidad complutense de Madrid; 2010.




2020     |     www.medigraphic.com